Skip to main content

DETECCION DE BIOMARCADORES EPIGENETICOS PARA EL DIAGNOSTICO Y PRONOSTICO DE CANCER DE OVARIO MEDIANTE EL USO DE PATAFORMAS NANOFOTONICAS ULTRASENSIBLES

PID2019-105132RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIÓ INSTITUT CATALÀ DE NANOCIÈNCIA I NANOTECNOLOGIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

One-step and real-time detection of microRNA-21 in human samples for lung cancer biosensing diagnosis

  • Calvo-Lozano, Olalla
  • García-Aparicio, Pablo
  • Raduly, Lajos-Zsolt
  • Estévez, M. Carmen
  • Berindan-Neagoe, Ioana
  • Ferracin, Manuela
  • Lechuga, Laura M.
The rapid diagnosis of cancer, especially in its early stages, is crucial for on-time medical treatment and for increasing the patient survival rate. Lung cancer shows the highest mortality rate and the lowest 5-year survival rate due to the late diagnosis in advanced cancer stages. Providing rapid and reliable diagnostic tools is a top priority to address the problem of a delayed cancer diagnosis. We introduce a nanophotonic biosensor for the direct and real-time detection in human plasma of the microRNA-21-5p biomarker related to lung cancer. The biosensor employs a silicon photonic bimodal interferometric waveguide that provides a highly sensitive detection in a label-free format. We demonstrate a very competitive detectability for direct microRNA-21-5p biomarker assays in human plasma samples (estimated LOD: 25 pM). The diagnostic capability of our biosensor was validated by analyzing 40 clinical samples from healthy individuals and lung cancer patients, previously analyzed by reverse-transcription quantitative polymerase chain reaction (qRT-PCR). We could successfully identify and quantify the levels of microRNA in a one-step assay, without the need for DNA extraction or amplification steps. The study confirmed the significance of implementing this biosensor technique compared to the benchmarking molecular analysis and showed excellent agreement with previous results employing the traditional qRT-PCR. This work opens new possibilities for the true implementation of point-of-care biosensors that enable fast, simple, and efficient early diagnosis of cancer diseases., The ICN2 acknowledges the financial support from the Spanish Research Agency (AEI), Ministry of Science, Innovation, and Universities through the PREDICT (TEC2016-78515-R) and EROICA PID2019-105132RB-I00) projects. ICN2 is funded by the CERCA Program/Generalitat de Catalunya and supported by the Severo Ochoa Centres of Excellence program funded by the Spanish Research Agency (AEI, grant no. SEV-2017-0706). O.C-L. acknowledges the economic support from the Spanish Ministry of Science and Innovation and the Spanish Research Agency and the European Social Fund (ESF) (ref. BES-2017-080527) linked to the PREDICT project. Research Center for Functional Genomics, Biomedicine and Translational Medicine acknowledges “Clinical and economic impact of personalized targeted anti-microRNA therapies in reconverting lung cancer chemoresistance”, CANTEMIR, no. POC-P_37_796/2016. This work was supported by the FLAG-ERA grant LEGOCHIP, funded by the Italian National Research Council and the Spanish National Research Agency (PCI2019-111890-2)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Integrated optical bimodal waveguide biosensors: Principles and applications

  • Torrijos, Luis
  • Lisboa, Bárbara D.
  • Soler, María
  • Lechuga, Laura M.
  • García-Rupérez, Jaime
Integrated optical biosensors have become one of the most compelling technologies for the achievement of highly sensitive, multianalyte, portable and easy to use point-of-care (POC) devices with tremendous impact in healthcare and environmental protection, among other application fields. In this context, bimodal waveguide (BiMW) interferometers have emerged over the last years as a powerful biosensor technology providing the benefits of extreme sensitivity under a label-free scheme, reliability and robustness within a highly compact footprint that can be integrated and multiplexed in lab-on-a-chip (LOC) platforms. In this review, we provide an overview of the state-of-the-art about integrated optical BiMW biosensors from the theoretical fundamentals to their practical implementation. Furthermore, we explore recent advances such as novel designs, integration in specific LOC systems and its application in real biosensing scenarios. Final remarks and perspectives on the potential impact of these biosensor interferometric structures are also provided, as well as some limitations that must be addressed in next steps., LTM and JGR acknowledge the support from the Spanish MCIN/AEI/10.13039/501100011033 through the PID2019-106965RB-C21 project and by the European Union through the operational program of the European Regional Development Fund (FEDER) of the Valencia Regional Government 2014-2020. BDL, MS, and LML acknowledge support of FLAG-ERA grant LEGOCHIP, funded by the Spanish Research Agency (AEI, Ref. PCI2019-111890-2), and financial support from EROICA project (Spanish Ministry of Science and Innovation MCIN, Ref. PID2019-105132RB-I00). The ICN2 is funded by the CERCA program/Generalitat de Catalunya and supported by the Severo Ochoa Centers of Excellence program, funded by the Spanish Research Agency (AEI, grant SEV-2017-0706).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Integrated optical bimodal waveguide biosensors, principles and applications

  • Torrijos-Morán, Luis
  • Lisboa, Bárbara|||0000-0002-3231-7411
  • Soler Aznar, Maria|||0000-0001-7232-2277
  • Lechuga, Laura M|||0000-0001-5187-5358
  • García-Rupérez, J.
Integrated optical biosensors have become one of the most compelling technologies for the achievement of highly sensitive, multianalyte, portable and easy to use point-of-care (POC) devices with tremendous impact in healthcare and environmental protection, among other application fields. In this context, bimodal waveguide (BiMW) interferometers have emerged over the last years as a powerful biosensor technology providing the benefits of extreme sensitivity under a label-free scheme, reliability and robustness within a highly compact footprint that can be integrated and multiplexed in lab-on-a-chip (LOC) platforms. In this review, we provide an overview of the state-of-the-art about integrated optical BiMW biosensors from the theoretical fundamentals to their practical implementation. Furthermore, we explore recent advances such as novel designs, integration in specific LOC systems and its application in real biosensing scenarios. Final remarks and perspectives on the potential impact of these biosensor interferometric structures are also provided, as well as some limitations that must be addressed in next steps.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

One-step and real-time detection of microRNA-21 in human samples for lung cancer biosensing diagnosis

  • Calvo Lozano, Olalla|||0000-0001-5486-2237
  • García Aparicio, Pablo|||0000-0001-9908-9639
  • Raduly, Lajos-Zsolt|||0000-0002-3926-5423
  • Estévez, M. Carmen|||0000-0003-3694-7186
  • Berindan Neagoe, Ioana|||0000-0001-5828-1325
  • Ferracin, Manuela|||0000-0002-1595-6887
  • Lechuga, Laura M|||0000-0001-5187-5358
The rapid diagnosis of cancer, especially in its early stages, is crucial for on-time medical treatment and for increasing the patient survival rate. Lung cancer shows the highest mortality rate and the lowest 5-year survival rate due to the late diagnosis in advanced cancer stages. Providing rapid and reliable diagnostic tools is a top priority to address the problem of a delayed cancer diagnosis. We introduce a nanophotonic biosensor for the direct and real-time detection in human plasma of the microRNA-21-5p biomarker related to lung cancer. The biosensor employs a silicon photonic bimodal interferometric waveguide that provides a highly sensitive detection in a label-free format. We demonstrate a very competitive detectability for direct microRNA-21-5p biomarker assays in human plasma samples (estimated LOD: 25 pM). The diagnostic capability of our biosensor was validated by analyzing 40 clinical samples from healthy individuals and lung cancer patients, previously analyzed by reverse-transcription quantitative polymerase chain reaction (qRT-PCR). We could successfully identify and quantify the levels of microRNA in a one-step assay, without the need for DNA extraction or amplification steps. The study confirmed the significance of implementing this biosensor technique compared to the benchmarking molecular analysis and showed excellent agreement with previous results employing the traditional qRT-PCR. This work opens new possibilities for the true implementation of point-of-care biosensors that enable fast, simple, and efficient early diagnosis of cancer diseases.